EsoCap announces the Presentation of the ACESO Trial Design at the Congress of the EAACI

Presentation of the ACESO-Trial Design, a randomized, placebo-controlled, double-blind trial evaluating the efficacy, tolerability, and safety of a novel delivery system (ESO-101) for topical esophageal treatment. ESO-101, EsoCap’s lead product…

Continue Reading EsoCap announces the Presentation of the ACESO Trial Design at the Congress of the EAACI

EsoCap featured in Fierce Pharma

EsoCap AG has been featured in Fierce Pharma Online. “We are extremely pleased that Fierce Pharma Online reviewed EsoCap’s unique and innovative topical drug delivery system to the esophagus and…

Continue Reading EsoCap featured in Fierce Pharma

EsoCap holds a multidisciplinary scientific advisory board meeting with thirteen international experts

EsoCap AG organized a multidisciplinary scientific advisory board meeting in Zurich with thirteen international experts on June 27, 2019. As an introduction, Prof. Werner Weitschies, Center for Drug Absorption and…

Continue Reading EsoCap holds a multidisciplinary scientific advisory board meeting with thirteen international experts

EsoCap announces authorisation of capital increase by extraordinary general assembly and successful closing of its private placement offering

EsoCap AG announced that a capital increase has been authorized by the Extraordinary General Assembly, held on April 11, 2019, followed by successful completion of a private placement financing. The…

Continue Reading EsoCap announces authorisation of capital increase by extraordinary general assembly and successful closing of its private placement offering

EsoCap one of just a handful of companies selected to present at the Bio-Europe conference start up spotlight on March 26, 2019

EsoCap AG is one of just a handful of companies in the area of biotech and medtech selected to present at the Bio-Europe conference start-up spotlight on March 26th, 2019 in Vienna.

Continue Reading EsoCap one of just a handful of companies selected to present at the Bio-Europe conference start up spotlight on March 26, 2019

EsoCap holds a scientific advisory board meeting in eosinophilic esophagitis

EsoCap AG organized a scientific advisory board meeting with eight international experts in Eosinophilic Esophagitis (EoE) in Zürich on June 14th, 2018. Prof. Dr. Werner Weitschies, Head of the Center of Drug Absorption and Transport at the University of Greifswald gave a keynote presentation on EsoCap’s unique drug delivery platform.

Continue Reading EsoCap holds a scientific advisory board meeting in eosinophilic esophagitis